DongKook Pharmaceutical Co., Ltd.
KOE: 086450.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Heung-Ju Oh
- Employees
- 1,092
- Headquarters
- Seoul, South Korea
- IPO year
- 2007
- Market cap
- ₩1T
- Website
- https://www.dkpharm.co.kr
Loading 086450…
Loading profile data…Frequently asked questions about 086450
What does DongKook Pharmaceutical Co., Ltd. (086450.KQ) do?
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable dr...
Where does 086450.KQ trade?
DongKook Pharmaceutical Co., Ltd. (086450.KQ) trades on the KOSDAQ.
What sector is 086450.KQ in?
DongKook Pharmaceutical Co., Ltd. (086450.KQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of DongKook Pharmaceutical Co., Ltd.?
Heung-Ju Oh is the chief executive officer of DongKook Pharmaceutical Co., Ltd. (086450.KQ).
Where is DongKook Pharmaceutical Co., Ltd. headquartered?
DongKook Pharmaceutical Co., Ltd. is headquartered in South Korea.
Does 086450.KQ pay a dividend?
Yes — DongKook Pharmaceutical Co., Ltd. (086450.KQ) paid a trailing twelve-month dividend of KRW 200.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 086450.KQ go public?
DongKook Pharmaceutical Co., Ltd. (086450.KQ) completed its initial public offering in 2007.